Quantifying the economic impact of premature mortality from cirrhosis in Spain.

IF 2.8 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Current Medical Research and Opinion Pub Date : 2025-03-01 Epub Date: 2025-03-24 DOI:10.1080/03007995.2025.2480187
Josep Darbà, Meritxell Ascanio
{"title":"Quantifying the economic impact of premature mortality from cirrhosis in Spain.","authors":"Josep Darbà, Meritxell Ascanio","doi":"10.1080/03007995.2025.2480187","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Excessive alcohol consumption is a major contributor to illness and mortality on a global scale. Per-capita alcohol consumption rose from 5.5 litres in 2005 to 6.4 litres in 2016 and is projected to reach 7.6 litres by 2030. In 2019, alcohol was associated with roughly a quarter of all cirrhosis-related deaths worldwide. The aim of this study is to assess the economic impact of premature mortality due to cirrhosis in Spain.</p><p><strong>Methods: </strong>To estimate the economic impact of premature mortality due to cirrhosis, we utilized the human capital method. This method involved collecting data on mortality rates, average salaries, and unemployment rates. Our objective was to quantify the financial implications of cirrhosis-related deaths, offering valuable insights for policymakers and healthcare professionals.</p><p><strong>Results: </strong>In 2022, 45% of cirrhosis deaths occurred among individuals of working age. This resulted in the loss of 20,190 years of potential life lost (YPLL), contributing to productivity losses totalling €20.4 billion over a decade. These statistics highlight the significant economic and societal burdens associated with cirrhosis mortality.</p><p><strong>Conclusions: </strong>Over the past two decades, there has been a global increase in alcohol consumption, a trend expected to persist and possibly escalate through 2030. As a direct consequence, projections indicate a corresponding increase in cirrhosis-related deaths over the coming decade. This anticipated rise underscores the ongoing public health challenge posed by alcohol-related liver diseases worldwide.</p>","PeriodicalId":10814,"journal":{"name":"Current Medical Research and Opinion","volume":" ","pages":"441-446"},"PeriodicalIF":2.8000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Medical Research and Opinion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03007995.2025.2480187","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Excessive alcohol consumption is a major contributor to illness and mortality on a global scale. Per-capita alcohol consumption rose from 5.5 litres in 2005 to 6.4 litres in 2016 and is projected to reach 7.6 litres by 2030. In 2019, alcohol was associated with roughly a quarter of all cirrhosis-related deaths worldwide. The aim of this study is to assess the economic impact of premature mortality due to cirrhosis in Spain.

Methods: To estimate the economic impact of premature mortality due to cirrhosis, we utilized the human capital method. This method involved collecting data on mortality rates, average salaries, and unemployment rates. Our objective was to quantify the financial implications of cirrhosis-related deaths, offering valuable insights for policymakers and healthcare professionals.

Results: In 2022, 45% of cirrhosis deaths occurred among individuals of working age. This resulted in the loss of 20,190 years of potential life lost (YPLL), contributing to productivity losses totalling €20.4 billion over a decade. These statistics highlight the significant economic and societal burdens associated with cirrhosis mortality.

Conclusions: Over the past two decades, there has been a global increase in alcohol consumption, a trend expected to persist and possibly escalate through 2030. As a direct consequence, projections indicate a corresponding increase in cirrhosis-related deaths over the coming decade. This anticipated rise underscores the ongoing public health challenge posed by alcohol-related liver diseases worldwide.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
量化西班牙肝硬化过早死亡的经济影响。
目标:在全球范围内,过度饮酒是导致疾病和死亡的一个主要因素。人均酒精消费量从2005年的5.5升上升到2016年的6.4升,预计到2030年将达到7.6升。2019年,全球约四分之一的肝硬化相关死亡与酒精有关。本研究的目的是评估西班牙肝硬化导致的过早死亡的经济影响。方法:采用人力资本法估计肝硬化导致的过早死亡的经济影响。这种方法包括收集死亡率、平均工资和失业率的数据。我们的目标是量化肝硬化相关死亡的财务影响,为决策者和医疗保健专业人员提供有价值的见解。结果:2022年,45%的肝硬化死亡发生在工作年龄人群中。这导致了20190年的潜在寿命损失(YPLL),在十年内造成了总计204亿欧元的生产力损失。这些统计数据突出了与肝硬化死亡率相关的重大经济和社会负担。结论:在过去的二十年中,全球酒精消费量一直在增加,这一趋势预计将持续下去,并可能在2030年升级。其直接后果是,预测表明,未来十年肝硬化相关死亡人数将相应增加。这一预期增长凸显了全球与酒精有关的肝脏疾病对公共卫生构成的持续挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Medical Research and Opinion
Current Medical Research and Opinion 医学-医学:内科
CiteScore
4.40
自引率
4.30%
发文量
247
审稿时长
3-8 weeks
期刊介绍: Current Medical Research and Opinion is a MEDLINE-indexed, peer-reviewed, international journal for the rapid publication of original research on new and existing drugs and therapies, Phase II-IV studies, and post-marketing investigations. Equivalence, safety and efficacy/effectiveness studies are especially encouraged. Preclinical, Phase I, pharmacoeconomic, outcomes and quality of life studies may also be considered if there is clear clinical relevance
期刊最新文献
Association between red blood cell distribution width and prediabetes: evidence from a single center cohort study. Assessment of the fetal Evans Index in pregnancies complicated by fetal growth restriction. Mistakes in the management of irritable bowel syndrome-diarrhoeal subtype and mimics: a narrative review. RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024-2025 RSV season survey. Tirzepatide compared with semaglutide in obesity disease: a subpopulation analysis applying Japan Society for the Study of Obesity criteria in the global SURMOUNT-5 trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1